Meiji’s mRNA Vaccine, Daiichi’s XBB.1.5 Jab Up for Nov. 27 PAFSC Session

Two COVID-19 vaccines developed respectively by Meiji Seika Pharma and Daiichi Sankyo have been added to the agenda of a key advisory panel meeting on November 27 for their approval, the health ministry said on November 16. Meiji’s ARCT-154 is...read more